Year 2025 / Volume 32 / Number 1

Abstract PDF HTML

Review

Phantom limb pain. Understanding and therapeutic approach beyond mirror therapy

Rev. Soc. Esp. Dolor. 2025; 32(1): 46-59 / DOI: 10.20986/resed.2025.4128/2024

Natalia Botero, Iván Mauricio González


ABSTRACT

The phantom limb pain is defined as a kind of neuropathic pain, however, it has its own characteristics due to the cortical changes that occur after an amputation and the phantom limb sensation that involves. The present review of the literature offers a synthesis of the pathophysiological theories, its presentation and clinical evaluation. Finally, explore the different treatment strategies both non -pharmacological and pharmacological, offering information on the usefulness of techniques and their relationship with the disease, as well as the results of the studies, mainly of the clinical trials and the systematic reviews and meta -analysis, to expose the best therapeutic options.



RESUMEN

El dolor de miembro fantasma se define como un tipo de dolor neuropático. Sin embargo, tiene unas características propias por los cambios corticales que se producen posterior a una amputación y la sensación fantasma que involucra. La presente revisión de la literatura ofrece una síntesis de las teorías fisiopatológicas de dicha entidad, su presentación y evaluación clínica. Por último, explora las distintas estrategias de tratamiento tanto no farmacológico como farmacológico, ofreciendo información sobre la utilidad de las técnicas y su relación con la fisiopatología de la enfermedad, así como los resultados de los estudios, principalmente de los ensayos clínicos y de las revisiones sistemáticas y metaanálisis, para exponer las mejores opciones terapéuticas.





Complete Article

Nuevo comentario

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comentarios

No comments in this article

Bibliografía

1. Boomgaardt J, Dastan K, Chan T, Shilling A, Abd-Elsayed A, Kohan L. An algorithm approach to phantom limb pain. J Pain Res. 2022;15:3349-67.
DOI: 10.2147/JPR.S355278
2. Stankevicius A, Wallwork SB, Summers SJ, Hordacre B, Stanton TR. Prevalence and incidence of phantom limb pain, phantom limb sensations and telescoping in amputees: A systematic rapid review. Eur J Pain. 2021;25(1):23-38.
DOI: 10.1002/ejp.1657
3. Hanyu-Deutmeyer AA, Cascella M, Varacallo M. Phantom limb pain. 2023. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
4. Culp CJ, Abdi S. Current understanding of phantom pain and its treatment. Pain Physician. 2022;25(7):E941-57.
5. Niraj S, Niraj G. Phantom limb pain and its psychologic management: A critical review. Pain Manag Nurs. 2014;15(1):349-64.
DOI: 10.1016/j.pmn.2012.04.001
6. Limakatso K, Bedwell GJ, Madden VJ, Parker R. The prevalence of phantom limb pain and associated risk factors in people with amputations: A systematic review protocol. Syst Rev. 2019;8(1):17. DOI: 10.1186/s13643-018-0938-8.
DOI: 10.1186/s13643-018-0938-8
7. Schone HR, Baker CI, Katz J, Nikolajsen L, Limakatso K, Flor H, et al. Making sense of phantom limb pain. J Neurol Neurosurg Psychiatry. 2022;93(8):833-43.
DOI: 10.1136/jnnp-2021-328428
8. Kooijman CM, Dijkstra PU, Geertzen JHB, Elzinga A, van der Schans CP. Phantom pain and phantom sensations in upper limb amputees: An epidemiological study. Pain. 2000;87(1):33-41.
DOI: 10.1016/S0304-3959(00)00264-5
9. Kikkert S, Mezue M, O'Shea J, Henderson Slater D, Johansen-Berg H, Tracey I, et al. Neural basis of induced phantom limb pain relief. Ann Neurol. 2019;85(1):59-73.
DOI: 10.1002/ana.25371
10. Makin TR, Flor H. Brain (re)organisation following amputation: Implications for phantom limb pain. Neuroimage. 2020;218:116943.
DOI: 10.1016/j.neuroimage.2020.116943
11. Melzack R. Phantom limbs, the self and the brain (the D. O. Hebb Memorial Lecture). Canadian Psychology / Psychologie canadienne. 1989;30(1):1-16.
12. Stover G, Prahlow N. Residual limb pain: An evidence-based review. NeuroRehabilitation. 2020;47(3):315-25.
DOI: 10.3233/NRE-208005
13. Kuffler DP. Origins of phantom limb pain. Mol Neurobiol. 2018;55(1):60-9.
DOI: 10.1007/s12035-017-0717-x
14. Collins KL, Russell HG, Schumacher PJ, Robinson-Freeman KE, O'Conor EC, Gibney KD, et al. A review of current theories and treatments for phantom limb pain. J Clin Invest. 2018;128(6):2168-76.
DOI: 10.1172/JCI94003
15. Diers M, Flor H. Phantomschmerz. Psychologische Behandlungsstrategien. Schmerz (Berlin, Germany). 2013;27(2):205-11; quiz 212-3.
DOI: 10.1007/s00482-012-1290-x
16. Luo Y, Anderson TA. Phantom limb pain: A review. Int Anesthesiol Clin. 2016;54(2):121-39.
DOI: 10.1097/AIA.0000000000000095
17. Limakatso K, Parker R. Treatment recommendations for phantom limb pain in people with amputations: An Expert Consensus Delphi Study. PM R. 2021;13(11):1216-26.
DOI: 10.1002/pmrj.12556
18. Aternali A, Katz J. Recent advances in understanding and managing phantom limb pain. F1000Res. 2019:8:F1000 Faculty Rev-1167.
DOI: 10.12688/f1000research.19355.1
19. Ramachandran VS, Rogers-Ramachandran D. Synaesthesia in phantom limbs induced with mirrors. Proc Biol Sci. 1996;263 (1369):377-86.
DOI: 10.1098/rspb.1996.0058
20. Cruciani RA, Nieto MJ. Fisiopatología y tratamiento del dolor neuropático: avances más recientes. Rev Soc Esp Dolor. 2006;13(5):312-27.
21. May S, Serpell M. Diagnosis and assessment of neuropathic pain. F1000 Med Rep. 2009;1:76.
DOI: 10.3410/M1-76
22. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152(1):14-27.
DOI: 10.1016/j.pain.2010.07.031
23. Ferraro F, Jacopetti M, Spallone V, Padua L, Traballesi M, Brunelli S, et al. Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation. Eur J Phys Rehabil Med. 2016;52(6):855-66.
24. Walker SM, Peters J, Verriotis M, Farag F, Jay MA, Howard RF. Sensitivity and specificity of a neuropathic screening tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in adolescents with moderate-severe chronic pain. J Pain. 2024;25(2):451-65.
DOI: 10.1016/j.jpain.2023.09.006
25. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19(5):306-14.
DOI: 10.1097/00002508-200309000-00004
26. Timmerman H, Steegers MAH, Huygen FJPM, Goeman JJ, van Dasselaar NT, Schenkels MJ, et al. Investigating the validity of the DN4 in a consecutive population of patients with chronic pain. PLoS One. 2017;12(11):e0187961.
DOI: 10.1371/journal.pone.0187961
27. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911-20.
DOI: 10.1185/030079906X132488
28. Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin. 2006;22(8):1555-65.
DOI: 10.1185/030079906X115702
29. Gálvez R, Pardo A, Cerón JM, Villasante F, Aranguren JL, Saldaña MT, et al. Adaptación al castellano y validación psicométrica del cuestionario ID-Pain© para la detección de dolor neuropático. Med Clin. 2008;131(15):572-8.
DOI: 10.1157/13128018
30. Fang J, Lian YH, Xie KJ, Cai SN. Pharmacological interventions for phantom limb pain. Chin Med J (Engl). 2013;126(3):542-9.
DOI: 10.3760/cma.j.issn.0366-6999.20121599
31. Cooper TE, Chen J, Wiffen PJ, Derry S, Carr DB, Aldington Det al. Morphine for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;5(5):CD011669.
DOI: 10.1002/14651858.CD011669.pub2
32. Kern K-U, Bialas P, Fangmann D. Retardiertes Tapentadol bei Phantomschmerzen. Schmerz. 2013;27(2):174-81.
DOI: 10.1007/s00482-013-1309-y
33. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain. 2001;90(1-2):47-55.
DOI: 10.1016/S0304-3959(00)00385-7
34. Kumar V, Garg R, Bharati SJ, Gupta N, Bhatanagar S, Mishra S, et al. Long-term high-dose oral morphine in phantom limb pain with no addiction risk. Indian J Palliat Care. 2015;21(1):85-7.
DOI: 10.4103/0973-1075.150198
35. Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythornthwaite JA, et al. Morphine versus mexiletine for treatment of postamputation pain: A randomized, placebo-controlled, crossover trial. Anesthesiology. 2008;109(2):289-96.
DOI: 10.1097/ALN.0b013e31817f4523
36. Malavera Angarita MA, Carrillo Villa S, Gomezese Ribero OF, García RG, Silva Sieger FA. Fisiopatología y tratamiento del dolor de miembro fantasma. Rev Colomb Anestesiol. 2014;42(1):40-6.
DOI: 10.1016/j.rca.2013.09.012
37. Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2016;10(10):CD006380.
DOI: 10.1002/14651858.CD006380.pub3
38. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002;27(5):481-6.
DOI: 10.1097/00115550-200209000-00007
39. Smith DG, Ehde DM, Hanley MA, Campbell KM, Jensen MP, Hoffman AJ, et al. Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. J Rehabil Res Dev. 2005;42(5):645-54.
DOI: 10.1682/JRRD.2005.05.0082
40. Hall N, Eldabe S. Phantom limb pain: A review of pharmacological management. Br J Pain. 2018;12(4):202-7.
DOI: 10.1177/2049463717747307
41. Robinson LR, Czerniecki JM, Ehde DM, Edwards WT, Judish DA, Goldberg ML, et al. Trial of amitriptyline for relief of pain in amputees: Results of a randomized controlled study. Arch Phys Med Rehabil. 2004;85(1):1-6.
DOI: 10.1016/S0003-9993(03)00476-3
42. Kuiken TA, Schechtman L, Harden RN. Phantom limb pain treatment with mirtazapine: A case series. Pain Pract. 2005;5(4):356-60.
DOI: 10.1111/j.1533-2500.2005.00038.x
43. Spiegel DR, Lappinen E, Gottlieb M. A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. Gen Hosp Psychiatry. 2010;32(2):228.e5-7.
DOI: 10.1016/j.genhosppsych.2009.05.012
44. Sato K, Higuchi H, Hishikawa Y. Management of phantom limb pain and sensation with milnacipran. J Neuropsychiatry Clin Neurosci. 2008;20(3):368.
DOI: 10.1176/jnp.2008.20.3.368
45. Chalana H. A case report of Milnacipran in phantom-limb pain. Asian J Psychiatr. 2010;3(3):155-6.
DOI: 10.1016/j.ajp.2010.07.009
46. Nikolajsen L, Gottrup H, Kristensen AG, Jensen TS. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analg. 2000;91(4):960-6.
DOI: 10.1097/00000539-200010000-00036
47. Maier C, Dertwinkel R, Mansourian N, Hosbach I, Schwenkreis P, Senne I, et al. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial. Pain. 2003;103(3):277-83.
DOI: 10.1016/S0304-3959(02)00456-6
48. Wiech K, Kiefer RT, Töpfner S, Preissl H, Braun C, Unertl K, et al. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg. 2004;98(2):408-13.
DOI: 10.1213/01.ANE.0000096002.53818.BD
49. Loy BM, Britt RB, Brown JN. Memantine for the treatment of phantom limb pain: A systematic review. J Pain Palliat Care Pharmacother. 2016;30(4):276-83.
DOI: 10.1080/15360288.2016.1241334
50. Schley M, Topfner S, Wiech K, Schaller HE, Konrad CJ, Schmelz M, et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. Eur J Pain. 2007;11(3):299-308.
DOI: 10.1016/j.ejpain.2006.03.003
51. Ben Abraham R, Marouani N, Weinbroum AA. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol. 2003;10(3):268-74.
DOI: 10.1245/ASO.2003.08.007
52. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input. Pain. 1996;67(1):69-77.
DOI: 10.1016/0304-3959(96)03080-1
53. Eichenberger Urs, Neff F, Sveticic G, Björgo S, Petersen-Felix S, Arenndt-Nielsen L, et al. Chronic phantom limb pain: The effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg. 2008;106 (4):1265-73, table of contents.
DOI: 10.1213/ane.0b013e3181685014
54. Chong DST, Pople M, Hardy TJ, Cowan A, Birchley D, Guy A, et al. Mirror therapy for the management of phantom limb pain: A single-center experience. Ann Vasc Surg. 2023;95:184-7.
DOI: 10.1016/j.avsg.2023.03.033
55. Casale R, Damiani C, Rosati V. Mirror therapy in the rehabilitation of lower-limb amputation: are there any contraindications? Am J Phys Med Rehabil. 2009;88(10):837-42.
DOI: 10.1097/PHM.0b013e3181b74698
56. Zaheer A, Malik AN, Masood T, Fatima S. Effects of phantom exercises on pain, mobility, and quality of life among lower limb amputees; a randomized controlled trial. BMC Neurol. 2021;21(1):416.
DOI: 10.1186/s12883-021-02441-z
57. Xie H-M, Zhang K-X, Wang S, Wang N, Wang N, Li X, et al. Effectiveness of mirror therapy for phantom limb pain: A systematic review and meta-analysis. Arch Phys Med Rehabil. 2022;103(5):988-97.
DOI: 10.1016/j.apmr.2021.07.810
58. Anaforoğlu Külünkoğlu B, Erbahçeci F, Alkan A. A comparison of the effects of mirror therapy and phantom exercises on phantom limb pain. Turk J Med Sci. 2019;49(1):101-09.
DOI: 10.3906/sag-1712-166
59. Gunduz ME, Pacheco-Barrios K, Bonin Pinto C, Duarte D, Vélez FGS, Gianlorenco ACL, et al. Effects of combined and alone transcranial motor cortex stimulation and mirror therapy in phantom limb pain: A randomized factorial trial. Neurorehabil Neural Repair. 2021;35(8):704-16.
DOI: 10.1177/15459683211017509
60. Campo-Prieto, P, Rodríguez-Fuentes G. Effectiveness of mirror therapy in phantom limb pain: a literature review. Neurologia. 2022;37(8):668-81.
DOI: 10.1016/j.nrl.2018.08.003
61. Tilak M, Isaac SA, Fletcher J, Vasanthan LT, Subbaiah RS, Babu A, et al. Mirror therapy and transcutaneous electrical nerve stimulation for management of phantom limb pain in amputees - A single blinded randomized controlled trial. Physiother Res Int. 2016;21(2):109-15.
DOI: 10.1002/pri.1626
62. Rothgangel A, Braun S, Smeets R, Beurskens A. Feasibility of a traditional and teletreatment approach to mirror therapy in patients with phantom limb pain: a process evaluation performed alongside a randomized controlled trial. Clin Rehabil. 2019;33(10):1649-60.
DOI: 10.1177/0269215519846539
63. Rothgangel A, Braun S, Smeets R, Beurskens A. Design and development of a telerehabilitation platform for patients with phantom limb pain: A user-centered approach. JMIR Rehabil Assist Technol. 2017;4(1):e2.
DOI: 10.2196/rehab.6761
64. Rothgangel A, Braun S, Winkens B, Beurskens A, Smeets R. Traditional and augmented reality mirror therapy for patients with chronic phantom limb pain (PACT study): results of a three-group, multicentre single-blind randomized controlled trial. Clin Rehabil. 2018;32(12):1591-608.
DOI: 10.1177/0269215518785948
65. Ulger O, Topuz S, Bayramlar K, Sener G, Erbahçeci F. Effectiveness of phantom exercises for phantom limb pain: A pilot study. J Rehabil Med. 2009;41(7):582-4.
DOI: 10.2340/16501977-0380
66. Rierola-Fochs S, Merchán-Baeza JA, Minobes-Molina E. Effectiveness of graded motor imagery protocol in phantom limb pain in amputed patient: Protocol of a randomized clinical trial. PLoS One. 2022;17(8):e0273356.
DOI: 10.1371/journal.pone.0273356
67. Morales-Osorio MA. Imaginería motora graduada en el síndrome de miembro fantasma con dolor. Rev Soc Esp Dolor. 2012 [citado 9 Nov 2023];19(4):209-16.
DOI: 10.1016/j.rh.2012.05.009
68. Limakatso K, Madden V, Manie S, Parker R. The effectiveness of graded motor imagery for reducing phantom limb pain in amputees: A randomised controlled trial. Physiotherapy. 2020;109:65-74.
DOI: 10.1016/j.physio.2019.06.009
69. Vaso A, Adahan HM, Gjika A, Zahaj S, Zhurda T, Vyshka G, et al. Peripheral nervous system origin of phantom limb pain. Pain. 2014;155(7):1384-91.
DOI: 10.1016/j.pain.2014.04.018
70. Mulvey MR, Radford HE, Fawkner HJ, Hirst L, Neumann V, Johnson MI. Transcutaneous electrical nerve stimulation for phantom pain and stump pain in adult amputees. Pain Prac. 2013;13(4):289-96.
DOI: 10.1111/j.1533-2500.2012.00593.x
71. Limakatso K. Managing acute phantom limb pain with transcutaneous electrical nerve stimulation: a case report. J Med Case Rep. 2023;17(1):209.
DOI: 10.1186/s13256-023-03915-z
72. Ambron E, Buxbaum LJ, Miller A, Stoll H, Kuchenbecker KJ, Coslett HB. Virtual reality treatment displaying the missing leg improves phantom limb pain: A small clinical trial. Neurorehabil Neural Repair. 2021;35(12):1100-11.
DOI: 10.1177/15459683211054164
73. Lotze M, Flor H, Grodd W, Larbig W, Birbaumer N. Phantom movements and pain. An fMRI study in upper limb amputees. Brain. 2001;124(Pt 11):2268-77.
DOI: 10.1093/brain/124.11.2268
74. Ichinose A, Sano Y, Osumi M, Sumitani M, Kumagaya S-I, Kuniyoshi Y. Somatosensory feedback to the cheek during virtual visual feedback therapy enhances pain alleviation for phantom arms. Neurorehabil Neural Repair. 2017;31(8):717-25.
DOI: 10.1177/1545968317718268
75. Osumi M, Ichinose A, Sumitani M, Wake N, Sano Y, Yozu A, et al. Restoring movement representation and alleviating phantom limb pain through short-term neurorehabilitation with a virtual reality system. Eur J Pain. 2017;21(1):140-7.
DOI: 10.1002/ejp.910
76. Thøgersen M, Andoh J, Milde C, Graven-Nielsen T, Flor H, Petrini L. Individualized augmented reality training reduces phantom pain and cortical reorganization in amputees: A proof of concept study. J Pain. 2020;21(11-12):1257-69.
DOI: 10.1016/j.jpain.2020.06.002
77. Lotze M, Birbaumer WG, Erb M, Huse E, Flor H. Does use of a myoelectric prosthesis prevent cortical reorganization and phantom limb pain? Nat Neurosci. 1999;2(6):501-2.
DOI: 10.1038/9145
78. Urits I, Seifert D, Seats A, Giacomazzi S, Kipp M, Orhurhu V, et al. Treatment strategies and effective management of phantom limb-associated pain. Curr Pain Headache Rep. 2019;23(9):64.
DOI: 10.1007/s11916-019-0802-0
79. Pacheco-Barrios K, Meng X, Fregni F. Neuromodulation techniques in phantom limb pain: a systematic review and meta-analysis. Pain Med. 202;21(10):2310-22.
DOI: 10.1093/pm/pnaa039

Artículos relacionados

Healthcare practitioner and other professionals' perspectives on gabapentinoid misuse and dependence: a systematic review of qualitative studies

Rev. Soc. Esp. Dolor. 2025; 32(1): 69-90 / DOI: 10.1001/ejp.70116

Caudal epidural haemorrhagic patch: a safe alternative for spontaneous intracranial hypotension syndrome

Rev. Soc. Esp. Dolor. 2025; 32(1): 60-64 / DOI: 10.20986/resed.2025.4140/2024

Use of capsaicin 8 % patch in refractory chronic neuropathic pain: study of two cases series

Rev. Soc. Esp. Dolor. 2025; 32(1): 29-45 / DOI: 10.20986/resed.2026.4212/2025

Radiofrequency generators available in Spain for pain treatment

Rev. Soc. Esp. Dolor. 2025; 32(1): 20-28 / DOI: 10.20986/resed.2025.4182/2024

A pain research strategy for Europe: a european survey and position paper of the European Pain Federation EFIC

Rev. Soc. Esp. Dolor. 2024; 31(3): 185-214

Autoimmune pancreatitis in a patient with systemic lupus erythematosus: case report

Rev. Soc. Esp. Dolor. 2024; 31(3): 176-179 / DOI: 10.20986/resed.2025.4167/2024

Atypical Parsonage-Turner syndrome after COVID-19 vaccine. A case report and literature review

Rev. Soc. Esp. Dolor. 2024; 31(3): 169-175 / DOI: 10.20986/resed.2025.4120/2023

The role of low-dose radiotherapy in the management of arthrosis pain: narrative literature review

Rev. Soc. Esp. Dolor. 2024; 31(3): 157-164 / DOI: 10.20986/resed.2025.4105/2023

Clinical efficacy of plasma rich in platelets injection in knee arthrotis

Rev. Soc. Esp. Dolor. 2024; 31(3): 141-149 / DOI: 10.20986/resed.2025.4112/2023

Credibility, readability and content analysis of treatment recommendations for adolescents with nonspecific back pain published on consumer websites

Rev. Soc. Esp. Dolor. 2024; 31(2): 121-135 / DOI: 10.1002/ejp.2282

Integrando la educación en ciencia del dolor en un tratamiento multicomponente para personas con fibromialgia: una guía práctica clínica

Rev. Soc. Esp. Dolor. 2024; 31(2): 106-120 / DOI: 10.20986/resed.2025.4157/2024

Adverse drug reactions associated with the prescription of oral solutions based on Cannabis sativa extracts: a post-marketing pharmacovigilance study

Rev. Soc. Esp. Dolor. 2024; 31(2): 91-105 / DOI: 10.20986/resed.2025.4059/2023

Ultrasound guided BRILMA block for the management of post-mastectomy pain syndrome in oncological parients: a series of cases

Rev. Soc. Esp. Dolor. 2024; 31(2): 85-90 / DOI: 10.20986/resed.2024.4089/2023

Efficacy and safety of opioid use in chronic non-cancer pain: results of the survey of the opioid task force of the Spanish Pain Society. Delphi consensus

Rev. Soc. Esp. Dolor. 2024; 31(2): 65-74 / DOI: 10.20986/resed.2025.4088/2023

Prognostic value of preoperative mechanical hyperalgesia and neuropathic pain qualities for postoperative pain after total knee replacement

Rev. Soc. Esp. Dolor. 2024; 31(1): 47-62 / DOI: 10.1002/ejp.2295

Ultrasound-guided needle tenotomy in refractory epicondylitis

Rev. Soc. Esp. Dolor. 2024; 31(1): 45-46 / DOI: 10.20986/resed.2017.3521/2016

Tolerance to intrathecal baclofen: clinical case report

Rev. Soc. Esp. Dolor. 2024; 31(1): 40-44 / DOI: 10.20986/resed.2024.4076/2023

Sexual function behavior in men with non-oncological chronic low back pain in a pain clinic of the city of Manizales, Colombia

Rev. Soc. Esp. Dolor. 2024; 31(1): 23-31 / DOI: 10.20986/resed.2024.4113/2023

Analgesic efficacy of tapentadol, alone or in combination, in patients with neuropathic pain (DN): experience in 80 cases

Rev. Soc. Esp. Dolor. 2024; 31(1): 12-15 / DOI: 10.20986/resed.2024.4083/2023

Clinical assessment of chronic pain in children and adolesecents: recommendations of the working group on pediatric pain of the Spanish Pain Society

Rev. Soc. Esp. Dolor. 2024; 31(1): 2-11 / DOI: 10.20986/resed.2024.4073/2023

Pain trajectories and neuropathic pain symptoms following lung cancer surgery: a prospective cohort study

Rev. Soc. Esp. Dolor. 2023; 30(4): 270-283 / DOI: 10.1002/ejp.2265

Abdominopelvic neuropathic pain secondary to involvement of the anterior cutaneous, iliohypogastric, and ilioinguinal nerves: case report and review of the literature

Rev. Soc. Esp. Dolor. 2023; 30(4): 265-269 / DOI: 10.20986/resed.2024.4054/2023

Fibromyalgia, mitochondrial dysfunction, oxidative stress and inflammation: ozone as a multitarget treatment. Case report and review of literature

Rev. Soc. Esp. Dolor. 2023; 30(4): 258-264 / DOI: 10.20986/resed.2023.3987/2022

Characteristics and effectiveness of therapeutic exercise on cancer-related fatigue: a systematic review

Rev. Soc. Esp. Dolor. 2023; 30(4): 250-259 / DOI: 10.20986/resed.2023.4098/2023

Exosomes as a potential therapeutic strategy for low back pain: literature review

Rev. Soc. Esp. Dolor. 2023; 30(4): 243-249 / DOI: 10.20986/resed.2023.4075/2023

Care needs of intrathecal infusion therapy in patients with cancer pain

Rev. Soc. Esp. Dolor. 2023; 30(4): 227-242 / DOI: 10.20986/resed.2024.4099/2023

Continuous electrical stimulation for the treatment of trigeminal neuralgia. A systematic review

Rev. Soc. Esp. Dolor. 2023; 30(4): 217-226 / DOI: 10.20986/resed.2023.4043/2022

A case of neuralgic amyotrophy after vaccination against COVID-19

Rev. Soc. Esp. Dolor. 2023; 30(3): 187-190 / DOI: 10.20986/resed.2023.4021/2022

Ultrasound-guided ankle nerve block as adjuvant therapy in chronic pain after occupational injury.

Rev. Soc. Esp. Dolor. 2023; 30(3): 178-186 / DOI: 10.20986/resed.2023.4035/2022

Effectiveness of adding posterior capsule stretching after an exercise program in patients with subacromial impingement syndrome: a randomized clinical study

Rev. Soc. Esp. Dolor. 2023; 30(3): 168-177 / DOI: 10.20986/resed.2023.3927/2021

A road trip to chemotherapy-induced neuropathic pain

Rev. Soc. Esp. Dolor. 2023; 30(3): 155-156 / DOI: 10.20986/resed.2023.4110/2023

Pain paths among post-COVID-19 condition subjects: a prospective cross-sectional study with in-person evaluation

Rev. Soc. Esp. Dolor. 2023; 30(2): 131-145 / DOI: 10.1002/ejp.2094

Effect of therapeutic exercise in persons with sacroiliac joint dysfunction: a systematic review and meta-analysis

Rev. Soc. Esp. Dolor. 2023; 30(2): 95-108 / DOI: 10.20986/resed.2023.4034/2022

Knowledge, attitudes, and beliefs towards the disease in women with fibromyalgia. A qualitative study based on a focus group

Rev. Soc. Esp. Dolor. 2023; 30(2): 79-94 / DOI: 10.20986/resed.2023.4022/2022

Observational, prospective and multicenter study on the use of transmucosal fentanyl citrate in regular clinical practice for the control of breakthrough pain crises in cancer patients

Rev. Soc. Esp. Dolor. 2023; 30(2): 72-78 / DOI: 10.20986/resed.2023.4028/2022

Not just low back pain: atypical manifestation of aortic aneurysm

Rev. Soc. Esp. Dolor. 2023; 30(1): 60-62 / DOI: 10.20986/resed.2022.3983/2022

Effects of transcranial direct current stimulation in pain and opioid consumption after spine surgery

Rev. Soc. Esp. Dolor. 2023; 30(1): 49-59 / DOI: 10.1002/ejp.1985

Pulsed radiofrequency of the supraescapular nerve in the treatment of painful shoulder

Rev. Soc. Esp. Dolor. 2023; 30(1): 36-48 / DOI: 10.20986/resed.2023.4046/2022

Effectiveness of cluneal nerve block for the treatment of chronic low back pain

Rev. Soc. Esp. Dolor. 2023; 30(1): 30-35 / DOI: 10.20986/resed.2023.4023/2022

Review of the remission and management of a cancer related pain population to a pain unit. What can we improve?

Rev. Soc. Esp. Dolor. 2023; 30(1): 7-14 / DOI: 10.20986/resed.2023.4010/2022

Effectiveness of electroacupuncture and moxibustion in the treatment of postoperative anterior cruciate ligament graft pain with meniscal remodeling. Case study UNEVT 2022

Rev. Soc. Esp. Dolor. 2022; 29(3): 192-195 / DOI: 10.20986/resed.2022.4009/2022

Treatment of painful scars with 5 % lidocaine patch: clinical cases report

Rev. Soc. Esp. Dolor. 2022; 29(3): 187-191 / DOI: 10.20986/resed.2022.3997/2022

Usefulness of percutaneous basivertebral nerve thermorizotomy for the treatment of chronic low back pain. Literature review

Rev. Soc. Esp. Dolor. 2022; 29(3): 169-174 / DOI: 10.20986/resed.2022.4044/2022

Efficacy of physiotherapy on the anxiety and depression in patients with chronic pain: a systematic review

Rev. Soc. Esp. Dolor. 2022; 29(3): 157-168 / DOI: 10.20986/resed.2022.3994/2022

Single eco-guided intra-articular injection of hyaluronic acid in symptomatic coxarthrosis: retrospective study of the efficacy of two presentations

Rev. Soc. Esp. Dolor. 2022; 29(3): 140-148 / DOI: 10.20986/resed.2022.4014/2022

Can we modify the evolution of neuropathic pain through the skin?

Rev. Soc. Esp. Dolor. 2022; 29(3): 129-131 / DOI: 10.20986/resed.2022.4052/2022

Peripheral facial palsy following glossopharyngeal block: a case report

Rev. Soc. Esp. Dolor. 2022; 29(2): 114-118 / DOI: 10.20986/resed.2022.3963/2021

The biopsychosocial nature of chronic pelvic floor pain: a narrative review

Rev. Soc. Esp. Dolor. 2022; 29(2): 97-113 / DOI: 10.20986/resed.2022.3981/2022

Myofascial pain syndrome in the female pelvic floor musculature. Narrative review of the literature

Rev. Soc. Esp. Dolor. 2022; 29(2): 88-96 / DOI: 10.20986/resed.2022.3970/2022

Attitudes and current knowledge of the spanish pain treatment specialist regarding medical cannabis

Rev. Soc. Esp. Dolor. 2022; 29(13): 52-57 / DOI: 10.20986/resed.2022.4032/2022

Medical cannabis treatment in patients with visceral chronic pain

Rev. Soc. Esp. Dolor. 2022; 29(13): 32-42 / DOI: 10.20986/resed.2022.4030/2022

Is medical cannabis useful for the treatment of fibromyalgia?

Rev. Soc. Esp. Dolor. 2022; 29(13): 27-31 / DOI: 10.20986/resed.2022.4029/2022

Cannabinoids in neuropathic pain: lights and shadows

Rev. Soc. Esp. Dolor. 2022; 29(13): 20-26 / DOI: 10.20986/resed.2022.4027/2022

Medical cannabis and cancer: benefits for cancer pain and other related symptoms

Rev. Soc. Esp. Dolor. 2022; 29(13): 14-19 / DOI: 10.20986/resed.2022.4026/2022

Current evidence of medical cannabis treatment in patients with chronic pain

Rev. Soc. Esp. Dolor. 2022; 29(13): 10-13 / DOI: 10.20986/resed.2022.4024/2022

Some preclinical results of cannabinoids and pain

Rev. Soc. Esp. Dolor. 2022; 29(13): 3-9 / DOI: 10.20986/resed.2022.4033/2022

Treatment alternatives for anemia in terminally ill patients diagnosed with oncology

Rev. Soc. Esp. Dolor. 2022; 29(1): 56-56 / DOI: 10.20986/resed.2022.3992/2022

Bone pain management with opioid medication in a patient with Camurati-Engelmann disease: a case report

Rev. Soc. Esp. Dolor. 2022; 29(1): 51-55 / DOI: 10.20986/resed.2021.3930/2021

Complex regional pain syndrome, rehabilitation, pharmacotherapy, psychology.

Rev. Soc. Esp. Dolor. 2022; 29(1): 34-50 / DOI: 10.20986/resed.2022.3978/2022

Use of 8 % capsaicin patches for the treatment of lumbar neuropathic pain

Rev. Soc. Esp. Dolor. 2022; 29(1): 28-33 / DOI: 10.20986/resed.2022.3995/2022

Peroneal neuropathy caused by an extraneural ganglion: literary review and treatment proposal. A non-positive case

Rev. Soc. Esp. Dolor. 2021; 28(6): 354-357 / DOI: 10.20986/resed.2022.3919/2021

Retrolaminar ultrasound guided block as analgesic treatment for post herpetic neuralgia: case report

Rev. Soc. Esp. Dolor. 2021; 28(6): 350-353 / DOI: 10.20986/resed.2022.3920/2021

Use of botulinum toxin for pain after amputation

Rev. Soc. Esp. Dolor. 2021; 28(6): 332-342 / DOI: 10.20986/resed.2022.3943/2021

Lumbar epidural steroids injections reduce catastrophism on the lumbosacral radicular syndrome

Rev. Soc. Esp. Dolor. 2021; 28(6): 325-331 / DOI: 10.20986/resed.2022.3947/2021

End-of-life transfusions in patients with an oncological diagnosis

Rev. Soc. Esp. Dolor. 2021; 28(6): 319-324 / DOI: 10.20986/resed.2022.3956/2021

Late onset of restless legs syndrome as a methadone withdrawal symptom in cancer patients: report of two cases

Rev. Soc. Esp. Dolor. 2021; 28(5): 298-300 / DOI: 10.20986/resed.2021.3889/2021

A new paradigm for the treatment of knee osteoarthritis: the role of hyaluronic acid, platelet-rich plasma (PRP) and ozone in the modulation of inflammation: a review

Rev. Soc. Esp. Dolor. 2021; 28(5): 282-291 / DOI: 10.20986/resed.2021.3903/2021

Thalalgic triad. A new clinical entity from a case series

Rev. Soc. Esp. Dolor. 2021; 28(5): 276-281 / DOI: 10.20986/resed.2021.3941/2021

Efficacy and complications of analgesic techniques for the treatment of moderate to severe postoperative acute pain

Rev. Soc. Esp. Dolor. 2021; 28(5): 264-265 / DOI: 10.20986/resed.2021.3942/2021

Descriptive study on the profile of patients sent to the Chronic Pain Treatment Unit of the University Hospital of Gran Canaria Dr. Negrín (UTDC-HUGCDN) as a basis for the reorganization of this

Rev. Soc. Esp. Dolor. 2021; 28(5): 254-263 / DOI: 10.20986/resed.2021.3939/2021

Capsaicin: a treatment to pick the mouth

Rev. Soc. Esp. Dolor. 2021; 28(5): 252-253 / DOI: 10.20986/resed.2021.3961/2021

Treatment by ultrasound-guided neurolysis with 6 % aqueous phenol of the pain component for post-amputation neuromas: report of a clinical case

Rev. Soc. Esp. Dolor. 2021; 28(4): 239-241 / DOI: 10.20986/resed.2021.3928/2021

Pharmacological osteonecrosis in maxillofacial surgery, period 2013-2019

Rev. Soc. Esp. Dolor. 2021; 28(4): 211-218 / DOI: 10.20986/resed.2021.3837/2020

Clinical recommendations for rehabilitation of people with fibromyalgia. A narrative review

Rev. Soc. Esp. Dolor. 2021; 28(4): 194-210 / DOI: 10.20986/resed.2021.3932/2021

Psychological factors associated with the adherence to analgesic treatment in patients with chronic pain: systematic review of the literature

Rev. Soc. Esp. Dolor. 2021; 28(4): 181-193 / DOI: 10.20986/resed.2021.3922/2021

The multifaceted reality of adherence to analgesic treatment

Rev. Soc. Esp. Dolor. 2021; 28(4): 175-176 / DOI: 10.20986/resed.2021.3945/2021

Persistent hiccups after epidural injection of betamethasone: a case report

Rev. Soc. Esp. Dolor. 2021; 28(2): 169-171 / DOI: 10.20986/resed.2021.3914/2021

Genicular nerve radiofrequency in osteoarthritis-related chronic knee pain

Rev. Soc. Esp. Dolor. 2021; 28(3): 154-168 / DOI: 10.20986/resed.2021.3900/2021

Observational and prospective study on the effectiveness and safety of the dorsal root ganglion stimulation in patients with refractory neuropathic pain

Rev. Soc. Esp. Dolor. 2021; 28(2): 148-156 / DOI: 10.20986/resed.2021.3879/2020

Prescribing habits for neuropathic pain management in Spain: results of the survey of the neuropathic pain working group of the Spanish Pain Society

Rev. Soc. Esp. Dolor. 2021; 28(3): 137-147 / DOI: 10.20986/resed.2021.3911/2021

Neuropathic pain: a constant challenge

Rev. Soc. Esp. Dolor. 2021; 28(2): 111-114 / DOI: 10.20986/resed.2021.3938/2021

Botulinum toxin for the treatment of myofascial pain syndrome

Rev. Soc. Esp. Dolor. 2021; 28(2): 100-110 / DOI: 10.20986/resed.2021.3902/2021

Risk of misuse of prescribed opioids in patients with chronic noncancer pain in a workers compensation system hospital in Chile

Rev. Soc. Esp. Dolor. 2021; 28(2): 82-91 / DOI: 10.20986/resed.2021.3845/2020

Evolution of low back pain in cancer patients treated with interventional pain management

Rev. Soc. Esp. Dolor. 2021; 28(2): 76-81 / DOI: 10.20986/resed.2021.3901/2021

Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome

Rev. Soc. Esp. Dolor. 2021; 28(2): 71-75 / DOI: 10.20986/resed.2021.3822/2020

Transfusions at the end of life. Review of some important considerations

Rev. Soc. Esp. Dolor. 2021; 28(1): 47-52 / DOI: 10.20986/resed.2021.3831/2020

Ozone and COVID-19: physiological bases and their therapeutic possibilities according to the evolutionary stage in SARS-CoV-2 infection

Rev. Soc. Esp. Dolor. 2021; 28(1): 27-36 / DOI: 10.20986/resed.2021.3810/2020

Management and perception of therapeutic adherence of breakthrough cancer pain by oncologists in Spain

Rev. Soc. Esp. Dolor. 2021; 28(1): 19-26 / DOI: 10.20986/resed.2021.3824/2020

Interventional management of osteoarthritic pain

Rev. Soc. Esp. Dolor. 2021; 28(13): 85-90 / DOI: 10.20986/resed.2021.3853/2020

Platelet rich plasma and intra-articular mesenchymal stem cells in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 80-84 / DOI: 10.20986/resed.2021.3858/2020

Intra-articular botulinum toxin and ozone in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 73-79 / DOI: 10.20986/resed.2021.3857/2020

Infiltrations of steroids and hyaluronic acid in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 64-72 / DOI: 10.20986/resed.2021.3854/2020

New pharmacological targets for osteoarthritis induced pain

Rev. Soc. Esp. Dolor. 2021; 28(13): 57-63 / DOI: 10.20986/resed.2021.3863/2020

Opioids in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 49-56 / DOI: 10.20986/resed.2021.3855/2020

Review of the pharmacological treatment of osteoarthritis pain with paracetamol, non-steroid anti-inflammatory (NSAIDSS) and selective cyclooxygenase-2 inhibitors (COXIB)

Rev. Soc. Esp. Dolor. 2021; 28(13): 43-48 / DOI: 10.20986/resed.2021.3864/2020

News in the clinical practice guidelines regarding the treatment of the hip, knee and hands osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 38-42 / DOI: 10.20986/resed.2021.3870/2020

Experimental models for pain evaluation in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 18-30 / DOI: 10.20986/resed.2021.3872/2020

Ethiopathogenic mechanism of osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 11-17 / DOI: 10.20986/resed.2021.3851/2020

Epidemiology, clinical impact and therapeutic objectives in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 4-10 / DOI: 10.20986/resed.2021.3874/2020

Transitional pain clinic

Rev. Soc. Esp. Dolor. 2020; 27(6): 369-374 / DOI: 10.20986/resed.2020.3840/2020

Study of pain in rehabilitation treatments

Rev. Soc. Esp. Dolor. 2020; 27(6): 361-368 / DOI: 10.20986/resed.2020.3809/2020

Impact of group psychological intervention on conventional radiofrequency tributary patients

Rev. Soc. Esp. Dolor. 2020; 27(6): 349-360 / DOI: 10.20986/resed.2020.3830/2020

Calcific tendinitis of the shoulder: risk factors and effectiveness of iontophoresis with acetic acid 5 % plus ultrasound: prospective quasi-experimental study at 5 years with 138 cases

Rev. Soc. Esp. Dolor. 2020; 27(6): 340-348 / DOI: 10.20986/resed.2020.3842/2020

A 14-month physiotherapy follow up to a child with Sandifer syndrome

Rev. Soc. Esp. Dolor. 2020; 27(5): 329-331 / DOI: 10.20986/resed.2020.3816/2020

School of non-oncologic chronic pain patients and opioid treatment

Rev. Soc. Esp. Dolor. 2020; 27(5): 324-328 / DOI: 10.20986/resed.2020.3804/2020

Opioid misuse in patients with cancer pain: an integrative systematic review of the literature

Rev. Soc. Esp. Dolor. 2020; 27(5): 306-315 / DOI: 10.20986/resed.2020.3801/2020

Identification of signs and symptoms for the diagnosis of discogenic low back pain: mapping review

Rev. Soc. Esp. Dolor. 2020; 27(5): 292-297 / DOI: 10.20986/resed.2020.3803/2020

Efficacy of lidocaine perfusions in fibromyalgia: a prospective cohort study

Rev. Soc. Esp. Dolor. 2020; 27(5): 287-291 / DOI: 10.20986/resed.2020.3796/2020

Back to the future in the treatment of postoperative acute pain

Rev. Soc. Esp. Dolor. 2020; 27(5): 285-286 / DOI: 10.20986/resed.2020.3850/2020

Splanchnic nerve block for the treatment of benign chronic abdominal pain. a case report and literature review

Rev. Soc. Esp. Dolor. 2020; 27(4): 273-277 / DOI: 10.20986/resed.2020.3818/2020

Continuous analgesic control in a patient with multiple rib fractures by placing a catheter in the deep plane of the erector muscle of the spine

Rev. Soc. Esp. Dolor. 2020; 27(4): 269-272 / DOI: 10.20986/resed.2020.3800/2020

Clinical pathophysiology in patients with sickle cell disease: the transition from acute to chronic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 257-268 / DOI: 10.20986/resed.2020.3814/2020

Gender determinants in the approach to chronic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 252-256 / DOI: 10.20986/resed.2020.3802/2020

Incidence of postmastectomy pain syndrome. Retrospective analysis

Rev. Soc. Esp. Dolor. 2020; 27(4): 246-251 / DOI: 10.20986/resed.2020.3797/2020

Sociodemographic and clinical characterization in patients with chronic back pain, Cienfuegos 2019

Rev. Soc. Esp. Dolor. 2020; 27(4): 239-245 / DOI: 10.20986/resed.2020.3798/2020

Spinal cord stimulation. Analysis of the diagnostic indications

Rev. Soc. Esp. Dolor. 2020; 27(4): 234-238 / DOI: 10.20986/resed.2020.3777/2019

Metamizole as an immunomodulator in neuropathic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 230-231 / DOI: 10.20986/resed.2020.3838/2020

Suboccipital decompression as an alternative in the treatment of pain secundary to occipital neuralgia: a case series

Rev. Soc. Esp. Dolor. 2020; 27(3): 221-226 / DOI: 10.20986/resed.2020.3791/2020

Analgesic effect of the capsaicin 8 % patch through the TRPV-1 receptor in a case of parkinson desease with located neuropathic pain

Rev. Soc. Esp. Dolor. 2020; 27(3): 216-22 / DOI: 10.20986/resed.2020.3786/2019

Spanish Pain Society (SPS). Healthcare recommendations for pain units in the face of progressive normalization of activity during the COVID-19 pandemic

Rev. Soc. Esp. Dolor. 2020; 27(3): 192-215 / DOI: 10.20986/resed.2020.3821/2020

Symptomatic treatment for migraña. Drugs used and related variables. Results of the european survey on work and migraine

Rev. Soc. Esp. Dolor. 2020; 27(3): 178-191 / DOI: 10.20986/resed.2020.3744/2019

Characteristics of patients suffering mild to severe pain treated with orodispersible tablets of paracetamol 325 mg/tramadol HCL 37,5mg (Paxiflas®) in comparison with other oral formulations containing the same combination. PROPAX study

Rev. Soc. Esp. Dolor. 2020; 27(3): 168-177 / DOI: 10.20986/resed.2020.3771/2019

Drug consumption used for musculoskeletal pain treatment in a cohort of blue-collar workers in Zaragoza (Spain)

Rev. Soc. Esp. Dolor. 2020; 27(3): 150-159 / DOI: 10.20986/resed.2020.3749/2019

Clinical experience with the implementation of a postdural puncture headache multidisciplinary protocol

Rev. Soc. Esp. Dolor. 2020; 27(2): 133-137 / DOI: 10.20986/resed.2020.3782/2019

Erector spinalis plane block as a neuropathic pain management in post-burned pediatric patient

Rev. Soc. Esp. Dolor. 2020; 27(2): 127-132 / DOI: 10.20986/resed.2020.3776/2019

Management of breakthrough pain associated with the cure of skin ulcers

Rev. Soc. Esp. Dolor. 2020; 27(2): 113-126 / DOI: 10.20986/resed.2020.3755/2019

Intra-articular ozone modulates inflammation, ameliorates pain and stiffness, improves function and has anabolic effect on knee osteoarthritis: a prospective quasiexperimental before-and-after study, 115 patients

Rev. Soc. Esp. Dolor. 2020; 27(2): 78-88 / DOI: 10.20986/resed.2020.3775/2019

The ozone paradigm in pain treatment

Rev. Soc. Esp. Dolor. 2020; 27(2): 69-71 / DOI: 10.20986/resed.2020.3807/2020

Conventional radiofrequency for genicular nerves in treatment of knee osteoarthritis

Rev. Soc. Esp. Dolor. 2020; 27(1): 59-60 / DOI: 10.20986/resed.2016.3515/2016

Review of the impact of acupuncture treatment on the management of nonspecific low back pain

Rev. Soc. Esp. Dolor. 2020; 27(1): 53-58 / DOI: 10.20986/resed.2020.3762/2019

Effectiveness of the association of lacosamide in trigeminal neuralgia

Rev. Soc. Esp. Dolor. 2020; 27(1): 50-52 / DOI: 10.20986/resed.2019.3738/2019

Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review

Rev. Soc. Esp. Dolor. 2020; 27(1): 37-49 / DOI: 10.20986/resed.2020.3717/2018

Efficacy of pregabalin, gabapentin and duloxetine in neuropathic pain verified by the p-curve analysis

Rev. Soc. Esp. Dolor. 2020; 27(1): 16-23 / DOI: 10.20986/resed.2020.3727/2019

Quasi-experimental study on effectiveness of music therapy to reduce anxiety before an interventional technique in the pain unit

Rev. Soc. Esp. Dolor. 2020; 27(1): 7-15 / DOI: 10.20986/resed.2020.3767/2019

News in the treatment of back pain: are the future cell therapies?

Rev. Soc. Esp. Dolor. 2020; 27(1): 3-4 / DOI: 10.20986/resed.2020.3792/2020

Abducens nerve palsy associated with dural puncture and neurovascular compression

Rev. Soc. Esp. Dolor. 2019; 26(6): 376-378 / DOI: 10.20986/resed.2019.3722/2018

Intratecal baclophene for the treatment of pain and spasticity in stiff man syndrome: a case report

Rev. Soc. Esp. Dolor. 2019; 26(6): 368-371 / DOI: 10.20986/resed.2019.3745/2019

Neurolytic procedures for pancreatic cáncer pain: a systematic review and a proposal for an algorithm treatment

Rev. Soc. Esp. Dolor. 2019; 26(6): 342-358 / DOI: 10.20986/resed.2019.3715/2018

Correlation study between diagnostic opportunity and pain severity in patients with fibromyalgia who enter the Nononcological Chronic Pain Unit at the San Borja Arriarán Clinical Hospital

Rev. Soc. Esp. Dolor. 2019; 26(6): 331-336 / DOI: 10.20986/resed.2019.3690/2018

Pyoderma gangrenosum, undocumented complication of a spinal cord stimulation

Rev. Soc. Esp. Dolor. 2019; 26(5): 309-312 / DOI: 10.20986/resed.2019.3725/2019

The medical doctors who perform their care and research work in pain units in the use of the internet: identification, characterization and determinants

Rev. Soc. Esp. Dolor. 2019; 26(5): 284-292 / DOI: 10.20986/resed.2019.3713/2018

Painful diabetic foot ulcer amputation avoided thanks to topical sevoflurane

Rev. Soc. Esp. Dolor. 2019; 26(4): 253-253 / DOI: 10.20986/resed.2018.3683/2018

Open-label, prospective, safety, tolerability and sensory function study after of capsaicin 8 % patch repeat treatment in non-diabetic peripheral neuropathic pain: stride study

Rev. Soc. Esp. Dolor. 2019; 26(4): 251-252 / DOI: 10.20986/resed.2017.3564/2017

NMDA antagonism in the treatment of cluster headache

Rev. Soc. Esp. Dolor. 2019; 26(4): 247-250 / DOI: 10.20986/resed.2019.3710/2018

Role of depressive symptomatology, catastrophism and expectation in the efficacy of interventional treatment in chronic low back pain

Rev. Soc. Esp. Dolor. 2019; 26(4): 227-232 / DOI: 10.20986/resed.2019.3704/2018

Characterization of pain in patients with breast cancer attending the Oncology Unit of the San José Hospital

Rev. Soc. Esp. Dolor. 2019; 26(4): 221-226 / DOI: 10.20986/resed.2019.3692/2018

Information and communication technologies applied among medical professionals who perform pain treatment

Rev. Soc. Esp. Dolor. 2019; 26(3): 175-183 / DOI: 10.20986/resed.2019.3709/2018

Pulsed radiofrequency of the dorsal root ganglion for chronic lumbosacral radicular syndrome refractory to epidural steroid injections

Rev. Soc. Esp. Dolor. 2019; 26(3): 166-174 / DOI: 10.20986/resed.2019.3702/2018

Sublingual fentanyl for the treatment of breakthrough cancer pain during allergic reactions to chemotherapy infusion

Rev. Soc. Esp. Dolor. 2019; 26(3): 148-153 / DOI: 10.20986/resed.2018.3689/2018

Explanations on the article “Recommendations based on evidence for the management of neuropathic pain (review of the literature)”

Rev. Soc. Esp. Dolor. 2019; 26(2): 134-137 / DOI: 10.20986/resed.2019.3723/2019

Main pharmacodynamic differences and receptor affinities between serotonin-norepinephrine reuptake inhibitors: clinical implications in the management of neuropathic pain

Rev. Soc. Esp. Dolor. 2019; 26(2): 131-133 / DOI: 10.20986/resed.2017.3597/2017

Pulsed radiofrequency treatment in the neuropathy of the pudendal nerve: report of a case

Rev. Soc. Esp. Dolor. 2019; 26(2): 128-129 / DOI: 10.20986/resed.2016.3517/2016

Does pregabalin is a safe drug? Heart failure associated with pregabalin

Rev. Soc. Esp. Dolor. 2019; 26(2): 124-125 / DOI: 10.20986/resed.2017.3537/2016

Myofascial pain syndrome as a cause of postoperative acute pain in hip surgery

Rev. Soc. Esp. Dolor. 2019; 26(2): 117-119 / DOI: 10.20986/resed.2019.3655/2018

Fast opioid detoxification

Rev. Soc. Esp. Dolor. 2019; 26(2): 95-102 / DOI: 10.20986/resed.2019.3681/2018

Profiles of personality and resilience in chronic pain: utility of the CDRISC-10 to discriminate between resilient and vulnerable types

Rev. Soc. Esp. Dolor. 2019; 26(2): 72-80 / DOI: 10.20986/resed.2018.3670/2018

Project adapta: adequacy of treatment in breakthrough cancer pain

Rev. Soc. Esp. Dolor. 2019; 26(1): 31-43 / DOI: 10.20986/resed.2018.3661/2018

Psychosocial factors in chronic cancer pain: a Delphi study

Rev. Soc. Esp. Dolor. 2019; 26(1): 21-30 / DOI: 10.20986/resed.2018.3658/2018

Dexmedetomidine versus endovenous lidocaine in breakthrough pain control and functionality in patients with lumbar stenosis

Rev. Soc. Esp. Dolor. 2019; 26(1): 14-20 / DOI: 10.20986/resed.2018.3656/2018

Effects of multimodal treatment in patients with complex regional pain syndrome type 1 with, at least, 6 months of evolution: a descriptive study

Rev. Soc. Esp. Dolor. 2019; 26(1): 6-13 / DOI: 10.20986/resed.2018.3651/2018

Micro RNAs: A new way for the management of neuropathic pain?

Rev. Soc. Esp. Dolor. 2019; 26(1): 2-3 / DOI: 10.20986/resed.2019.3730/2019

American Headache Society for the treatment of cluster headache guidelines

Rev. Soc. Esp. Dolor. 2018; 25(6): 362-365 / DOI: 10.20986/resed.2017.3539/2016

Dysphonia as side-effect dose-dependent during treatment with duloxetine

Rev. Soc. Esp. Dolor. 2018; 25(6): 359-359 / DOI: 10.20986/resed.2017.3528/2016

Evidence-based recommendations for the management of neuropathic pain (review of the literature)

Rev. Soc. Esp. Dolor. 2018; 25(6): 349-358 / DOI: 10.20986/resed.2018.3673/2018

Opinaudit study: clinical uses in breakthrough pain, is scientific evidence being followed up?

Rev. Soc. Esp. Dolor. 2018; 25(6): 325-334 / DOI: 10.20986/resed.2018.3634/2017

Use of major opioids for control of pain in hospitalized patients

Rev. Soc. Esp. Dolor. 2018; 25(6): 318-324 / DOI: 10.20986/resed.2018.3629/2017

Proctalgia and pudendal nerve entrapment: an association to know

Rev. Soc. Esp. Dolor. 2018; 25(6): 311-317 / DOI: 10.20986/resed.2018.3623/2017

Radiofrequency thermal and splanchnics nerves block

Rev. Soc. Esp. Dolor. 2018; 25(5): 303-304 / DOI: 10.20986/resed.2016.3509/2016

Implications of bioethics in the treatment of chronic pain: the change of paradigms

Rev. Soc. Esp. Dolor. 2018; 25(5): 291-300 / DOI: 10.20986/resed.2018.3666/2018

Farmacologic adyuvants with saving effect of opioids in the perioperative period

Rev. Soc. Esp. Dolor. 2018; 25(5): 278-290 / DOI: 10.20986/resed.2018.3663/2018

Platelet-rich plasma in treating peripheral neuropathic pain. Preliminary report

Rev. Soc. Esp. Dolor. 2018; 25(5): 263-270 / DOI: 10.20986/resed.2017.3625/2017

Pain in the elderly and in patients with cognitive deficit. A DELPHI study

Rev. Soc. Esp. Dolor. 2018; 25(5): 251-262 / DOI: 10.20986/resed.2017.3621/2017

Chrono study: prevalence of breakthrough pain among patients with non-cancer chronic pain in Andalusia, Spain

Rev Soc Esp Dolor 2018; 25(4): 214-221 / DOI: 10.20986/resed.2017.3626/2017

Expenditure, prescription and consumption of analgesic drugs before and during the economic crisis

Rev Soc Esp Dolor 2018; 25(3): 155-162 / DOI: 10.20986/resed.2017.3609/2017

Painometer v2®: a mobile application certified for monitoring patients with pain

Rev Soc Esp Dolor 2018; 25(2):112-120 / DOI: 10.20986/resed.2017.3555/2016

Analgesic efficacy of topical sevoflurane on wounds

Rev Soc Esp Dolor 2018; 25(2): 106-111 / DOI: 10.20986/resed.2017.3617/2017

Potential uses of Mirtazapine in palliative care beyond its antidepressant effect

Rev Soc Esp Dolor 2018; 25(1): 37-44 / DOI: 10.20986/resed.2017.3575/2017

Pain management in cancer patients receiving radiotherapy: GORVAMUR study, a prospective, observational, epidemiological study

Rev Soc Esp Dolor 2017; 24(5): 241-255 / DOI: 10.20986/resed.2017.3570/2017

Chronic pain: relationship with prefrontal symptoms and perceived stress

Rev Soc Esp Dolor 2017; 24(4): 179-187 / DOI: 10.20986/resed.2017.3540/2016

The effectiveness of electrical spinal-cord stimulation in type i complex regional pain syndrome. A literature review

Rev Soc Esp Dolor 2017; 24(4): 169-178 / DOI: 10.20986/resed.2016.3501/2016

Control of symptoms in terminally ill patients: effectiveness of opioid treatment for breakthrough dyspnea

Rev Soc Esp Dolor 2017; 24(4): 161-168 / DOI: 10.20986/resed.2017.3582/2017

Paxiflas®: new FDT combination of tramadol/paracetamol for treating moderate to severe pain

Rev Soc Esp Dolor 2017; 24(2):59-67 / DOI: 10.20986/resed.2017.3565/2017

Prevalence of breakthrough pain associated with chronic low back pain in Andalusia (COLUMBUS study)

Rev Soc Esp Dolor 2017; 24(3):116-124 / DOI: 10.20986/resed.2017.3548/2016

Effectiveness of hyaluronic acid intra-articular injections in treating knee osteoarthritis: results of a series of cases treated in a Pain Unit

Rev Soc Esp Dolor 2017; 24(2): 74-84 / DOI: 10.20986/resed.2016.3485/2016

Instrucciones para citar

Botero N, González I. Phantom limb pain. Understanding and therapeutic approach beyond mirror therapy. Rev Soc Esp Dolor 2025; 32(1): 46-59 / DOI: 1020986/resed20254128/2024


Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 6 veces.
Este artículo ha sido descargado 0 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 16/01/2024

Aceptado: 28/06/2025

Prepublicado: 29/07/2025

Publicado: 24/02/2026

Tiempo de prepublicación: 560 días

Tiempo de edición del artículo: 770 días


Compartir

Este artículo aun no tiene valoraciones.
Reader rating:
Rate this article:
Send by e-mail
© 2026 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexada en:
Política de Privacidad